Study Conducted at the Cleveland Clinic Determines that a Breath Test May Detect Lung Cancer
Researchers at the Cleveland Clinic announced the results of a clinical study demonstrating that a breath test may be able to detect the presence of lung cancer and even distinguish between different types of lung cancer. The researchers at the Cleveland Clinic used Metabolomx, a colorimetric sensor array breath test to determine the presence of lung cancer in individuals. The tests had an accuracy rate exceeding 80% in lung cancer detection. The tests identified the type of lung cancer (small cell, adenocarcinoma or squamous cell) with an accuracy rate of almost 90%.
These Metabolomx breath tests are being examined by doctors along with computerized tomography (CT) scans. Researchers hope that these new breath tests, which report active tumor metabolism, will be used in coordination with CT scans to assist clinicians in distinguishing between benign and malignant lung nodules. This study presents hope for more non-invasive ways to detect and diagnose lung cancer.
If you or someone you know has been diagnosed with lung cancer and has been exposed to asbestos or diesel fume exhaust, call Doran & Murphy at 1-800-374-2144 or contact us through email.